Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Why This AMD Analyst Is Lowering Price Target After Chipmaker's Stellar Q1

Advanced Micro Devices, Inc. (NASDAQ: NASDAQ) reported forecast-beating quarterly results on Tuesday and raised its full-year revenue guidance.

Benzinga

Morphic Holding: Q1 Earnings Insights

Morphic Holding (NASDAQ:MORF) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Tecnoglass: Q1 Earnings Insights

Tecnoglass (NASDAQ:TGLS) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Recap: Ionis Pharmaceuticals Q1 Earnings

Ionis Pharmaceuticals (NASDAQ:IONS) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Sinclair Broadcast Group: Q1 Earnings Insights

Sinclair Broadcast Group (NASDAQ:SBGI) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Sinclair Broadcast Group posted an EPS of $0.37.

Benzinga

Insiders Buy More Than $50M Of 3 Penny Stocks

Gold futures traded lower on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Benzinga

The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

$FDA Grants Fast Track designation To Aptose Biosciences for HM43239 in Relapsed/Refractory AML Patients and FLT3 Mutation$

FDA Grants Fast Track designation To Aptose Biosciences for HM43239 in Relapsed/Refractory AML Patients and FLT3 Mutation

Aptose Biosciences Inc. (NASDAQ: APTO) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to HM43239, an oral, myeloid kinome inhibitor, for the treatment of patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with FLT3 mutation.

Benzinga

Recap: BlackRock TCP Capital Q1 Earnings

BlackRock TCP Capital (NASDAQ:TCPC) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Mark Cuban, Pitbull, Steve Aoki And Paris Hilton Invest In Company Bringing NFTs To Life

A mobile animation app announced new investors Wednesday as it grows its platform, bringing non-fungible tokens to life.

Benzinga

Executives Buy Around $85M Of 4 Stocks

Although crude oil futures traded higher on Wednesday, there were a few notable insider trades.

Benzinga

CDW Clocks 23% Net Sales Growth In Q1; Margins Expand On Favorable Product Mix

CDW Corp (NASDAQ:CDW) reported first-quarter FY22 net sales growth of 23% year-on-year to $5.95 billion, beating the consensus of $5.67 billion. Average daily sales rose 23% Y/Y to $94.4 million. Net sales from the Total Corporate segment increased 45.5% Y/Y to $2.63 billion, and the Total Small Business segment rose 21.1% to $524…

Benzinga

Jim Cramer Shares His Thoughts On AT&T, Lucid Group And More

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Lucid Group, Inc. (NASDAQ: LCID) missed the quarter "so badly that I have to tell you, I’ve pulled in my horns on the name."

Benzinga

Vericel: Q1 Earnings Insights

Vericel (NASDAQ:VCEL) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Recap: Sinclair Broadcast Group Q1 Earnings

Sinclair Broadcast Group (NASDAQ:SBGI) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

Horizon Therapeutics: Q1 Earnings Insights

Horizon Therapeutics (NASDAQ:HZNP) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: EyePoint Pharmaceuticals Q1 Earnings

EyePoint Pharmaceuticals (NASDAQ:EYPT) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Harvard Bioscience Q1 Earnings

Harvard Bioscience (NASDAQ:HBIO) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Neurocrine Biosciences: Q1 Earnings Insights

Neurocrine Biosciences (NASDAQ:NBIX) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

Pacira BioSciences: Q1 Earnings Insights

Pacira BioSciences (NASDAQ:PCRX) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Lumentum Holdings Q3 Earnings

Lumentum Holdings (NASDAQ:LITE) reported its Q3 earnings results on Wednesday, May 4, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Gibraltar Industries Q1 Earnings

Gibraltar Industries (NASDAQ:ROCK) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

Wingstop: Q1 Earnings Insights

Wingstop (NASDAQ:WING) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Clovis Oncology: Q1 Earnings Insights

Clovis Oncology (NASDAQ:CLVS) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

10 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session

1 … 567 568 569 570

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Sinclair Broadcast Group

Sensient Technologies

15 stories

Ionis Pharmaceuticals

13 stories

Neurocrine Biosciences

11 stories

Horizon rapeutics

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.